Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC
Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC
Recruiting · NCT06348797 · Registry updated 2026-07-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC | Small Cell Lung Cancer Extensive Stage | Recruiting | Phase 1 | 2026-07-21 | NCT06348797 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 2 |
| Sichuan University | 55 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| West China Hospital Sichuan University | Chengdu | China | 12 |